Form 4: Sight Sciences CLO Sells Shares Post-Option Exercise

Sight Sciences' Chief Legal Officer, Jeremy B. Hayden, exercised stock options and subsequently sold 44,850 shares of common stock for approximately $8.08 per share, as part of a Rule 10b5-1 plan related to a marital separation agreement.

Summary

• Jeremy B. Hayden, Chief Legal Officer of Sight Sciences, Inc. (SGHT), engaged in transactions on November 25, 2025.
• Exercised stock options to acquire 37,560 shares of common stock at $1.96 per share.
• Exercised stock options to acquire an additional 7,290 shares of common stock at $1.96 per share.
• Immediately sold a total of 44,850 shares of common stock at a weighted average price of $8.08 per share.
• The sales were executed under a Rule 10b5-1 trading plan, established in connection with a marital separation agreement.
• The reporting person's former spouse will receive all proceeds from the shares sold.
• Following these transactions, Mr. Hayden beneficially owns 256,590 shares of common stock directly.
• Remaining derivative holdings include 40,000 and 8,000 stock options, both fully vested and exercisable at an exercise price of $1.96.

Sentiment

Score: 5

Explanation: The transaction is neutral to slightly negative. While the sale is for personal reasons and pre-planned, large insider sales can sometimes be misinterpreted by the market as a lack of confidence, even when explained.

Positives

• The options were exercised at a significantly lower price ($1.96) than the sale price ($8.08), indicating a substantial gain on the exercised options.
• The transaction was pre-planned under a Rule 10b5-1 plan, reducing concerns about opportunistic insider trading.

Negatives

• A significant sale of shares by a Chief Legal Officer, even for personal reasons, could be perceived negatively by some investors, potentially signaling a lack of confidence in the company's future, despite the stated reason.

Risks

• No specific risks to the company's operations or financial health are mentioned. The risk is more related to investor perception of insider selling.

Future Outlook

No forward-looking statements or guidance are provided in this Form 4 filing.

Management Comments

• The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in connection with, and pursuant to, the terms of a marital separation agreement previously entered into between the Reporting Person and his former spouse.
• The Reporting Person's spouse will receive all proceeds from the shares sold in the transactions.
• The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Industry Context

This Form 4 filing details an insider transaction and does not provide information relevant to broader industry trends or competitive analysis.

Comparison to Industry Standards

• This filing is a standard insider transaction report (Form 4) and does not contain information suitable for comparison to global benchmarks, comparable companies, projects, or results.

Related Party Transactions

• The proceeds from the sale of shares will be received by the reporting person's former spouse, as per the marital separation agreement.

Stakeholder Impact

• Shareholders: May view the insider sale with caution, though the pre-planned nature and personal reason mitigate some concerns.
• Employees: No direct impact mentioned.
• Customers: No direct impact mentioned.
• Suppliers: No direct impact mentioned.
• Creditors: No direct impact mentioned.

Next Steps

• No specific future actions, events, or milestones for the company are mentioned in this Form 4 filing.

Key Dates

Recommendation

While the insider sale is significant, it was executed under a pre-planned 10b5-1 agreement due to a marital separation, which mitigates concerns about a lack of confidence in the company's future. The transaction itself does not reflect on the operational performance or strategic direction of Sight Sciences. Investors should hold and monitor future company performance and other insider activity rather than reacting solely to this personally motivated sale.

Keywords

Sight Sciences, SGHT, Insider Trading, Form 4, Stock Options, Share Sale, Chief Legal Officer, 10b5-1 Plan, Marital Separation